On the other hand, the downregulation of CD40 expression mediated by the inhibition of TLR-9, mTOR1/2, or electron transport chain (ETC) sensitizes CLL cells to venetoclax [97, 98]. The gene discussed is CD40; the disease is B-cell chronic lymphocytic leukemia.